On October 6, 2026 Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary INTASYL siRNA gene-silencing platform, reported that Robert Bitterman, President and Chief Executive Officer, reported it will present INTASYL siRNA therapeutic platform, its differentiated delivery approach, and the Company’s strategic direction at The Global Markets Virtual Forum hosted by www.VirtualInvestorConferences.com (VIC) on October 8th, 2026.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"The Global Markets Virtual Forum offers a unique forum to highlight Phio’s differentiated siRNA therapeutic platform, which is designed to enhance immune-cell function in solid tumors and has demonstrated a strong safety profile," said Robert Bitterman, President and Chief Executive Officer of Phio Pharmaceuticals.
Presentation Details:
DATE: October 8th, 2026
TIME: 12:40 PM (EDT)
LINK: Phio Pharmaceuticals Corp. (NASDAQ: PHIO)
Availability for 1×1 Meetings: Robert Bitterman will be available for 1×1 meetings and can be scheduled with the link below:
DATE TIME
Thursday October 8, 2026 11:45 AM-2:15 PM (EDT)
Friday October 9, 2026 Noon – 4:30 PM (EDT)
Monday October 12, 2026 9 AM -1 PM (EDT)
LINK for 1×1 meetings: Event Details
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com
(Press release, Phio Pharmaceuticals, OCT 6, 2026, View Source [SID1234673220])